Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Matrix proceeds with full enrollment for IntraDose phase II trials

May 19, 1998

Batimastat enhances antitumor activity of cisplatin against ovarian cancer

May 19, 1998

Mechanism of antitumor activity of clotrimazole identified

May 18, 1998

U.S. patent issues for ImClone Systems' flk-1/KDR receptor-targeting antibodies

May 18, 1998

SU-5416 advances to phase I/II trials in Kaposi's sarcoma

May 18, 1998

Rhone-Poulenc Rorer expands licensing agreement with Enzon for Oncaspar

May 18, 1998

Sanofi receives expanded approval for oxaliplatin in France

May 15, 1998

Sparta completes patient treatment phase in Spartaject busulfan trial

May 15, 1998

Bis-imide antitumor agents developed at ADIR

May 14, 1998

Introgen receives patent protection for p53 gene therapy-chemotherapeutic drug combinations

May 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.